Federal Register / Vol. 79, No. 235 / Monday, December 8, 2014 / Notices 72687 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–1697] 

Privacy Act of 1974; Report of a New 

System of Records; Food and Drug 

Administration Commissioning of 

State and Local Officials 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of a Privacy Act system 

of records. 

SUMMARY: In accordance with the 

requirements of the Privacy Act of 1974 

(the Privacy Act) and the Food and Drug 

Administration’s (FDA or the Agency) 

regulations for the protection of privacy, 

FDA is publishing notice of a Privacy 

Act system of records entitled, ‘‘FDA 

Commissioning of State and Local 

Officials, HHS/FDA/ORA’’ System No. 

09–10–0022. FDA is deleting the System 

of Records Notice (SORN) for ‘‘FDA 

Credential Holder File, HHS/FDA/OC’’ 

System No. 09–10–0003, because the 

records covered by that SORN are now 

covered by this new SORN and by 

existing personnel records SORNs. The 

new system of records will contain 

information about State and local 

officials who have applied for an FDA 

commission that would allow them to 

assist FDA with its regulatory 

compliance and enforcement efforts. 

FDA will use the records in this system 

to assess qualifications of 

commissioning candidates, initiate 

background investigations, record the 

status of applications, and track the 

status of commissioned officials. 

DATES: Effective Date: The new system 

of records will be effective on December 

8, 2014 with the exception of the 

routine uses. The routine uses will be 

effective on January 22, 2015. Submit 

either electronic or written comments 

by January 22, 2015. 

ADDRESSES: You may submit comments 

by any of the following methods: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

Written Submissions 

Submit written submissions in the 

following ways: 

• Mail/Hand delivery/Courier (for 

paper submissions): Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. 

Instructions: All submissions received 

must include the Docket No. FDA– 

2014–N–1697 for this notice. All 

comments received may be posted 

without change to http://

www.regulations.gov, including any 

personal information provided. For 

additional information on submitting 

comments, see the ‘‘Comments’’ heading 

of the SUPPLEMENTARY INFORMATION

section of this document. 

Docket: For access to the docket to 

read background documents or 

comments received, go to http://

www.regulations.gov and insert the 

docket number, found in brackets in the 

heading of this document, into the 

‘‘Search’’ box and follow the prompts 

and/or go to the Division of Dockets 

Management, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. 

FOR FURTHER INFORMATION CONTACT: 

Ryan Cates, Office of Partnerships, Food 

and Drug Administration, Element 

Building, 12420 Parklawn Dr., 

Rockville, MD 20857, 301–796–5390, 

FAX: 301–827–3588, OP–ORA@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background on the New System and 

the Deleted System 

The FDA is establishing a new system 

of records referred to as the 

Commissioning of State and Local 

Officials (COSLO) system, to maintain 

records regarding State and local 

officials who apply to be commissioned 

by FDA. Under section 702(a)(1)(A) of 

the Federal Food, Drug, and Cosmetic 

Act (FD&C Act) (21 U.S.C. 372(a)(1)(A)), 

FDA can commission a health, food, or 

drug officer or employee of any State, 

territory, or political subdivision thereof 

(hereafter State and local officials) to 

conduct examinations and 

investigations for the purposes of the 

FD&C Act. 

In addition, FDA is deleting the SORN 

entitled ‘‘FDA Credential Holder File, 

HHS/FDA/OC’’ (System No. 09–10– 

0003). The records covered by that 

SORN (credential records for FDA 

employees and commissioned officials) 

will now be covered by this SORN for 

the COSLO system which contains 

records pertaining to commissioned 

officials, and by other existing 

personnel SORNs for records pertaining 

to FDA employees. 

Issued in Homeland Security 

Presidential Directive 12, ‘‘Policy for a 

Common Identification Standard for 

Federal Employees and Contractors,’’ 

FDA has completed the process of 

issuing Personal Identity Verification 

(PIV) badges to current employees and 

contractors, and will do the same for all 

new employees and contractors hired in 

the future. Records pertaining to those 

badges and background investigations 

are covered under HHS departmentwide SORN No. 09–90–0777 entitled 

‘‘Facility and Resource Access Control 

Records System.’’ Any additional 

records maintained to identify or 

manage FDA personnel designated to 

conduct examinations and inspections 

under the FD&C Act would be covered 

by HHS department-wide SORN No. 09– 

90–0018 entitled ‘‘Personnel Records in 

Operating Offices’’ or another personnel 

SORN. 

State and local officials who assist 

with FD&C Act examinations and 

inspections are issued one or two types 

of credentials that differ in scope. All 

commissioned individuals receive 

Certificates of Commission and are 

permitted to receive and review FDA 

documents. A subset of commissioned 

individuals also receive personal 

‘‘pocket credentials’’ identifying them as 

FDA commissioned officers and 

authorizing them to perform additional 

activities such as conducting 

inspections, collecting samples, and 

verifying records. To obtain pocket 

credentials, State and local officials 

undergo an Office of Personnel 

Management level 5 background 

investigation. FDA commission 

credentials are different from the PIV 

badges issued to FDA employees and 

contractors, and are manufactured and 

issued by FDA’s Office of Security 

Operations, and are not within the 

scope of HHS department-wide SORN 

No. 09–90–0777. 

II. The Privacy Act 

The Privacy Act of 1974 (Pub. L. 93– 

579) (5 U.S.C. 552a), as amended, 

governs the means by which the U.S. 

Government collects, maintains, and 

uses information about individuals in a 

system of records. A ‘‘system of 

records’’ is a group of any records under 

the control of a Federal Agency from 

which information about an individual 

is retrieved by the individual’s name or 

other personal identifier. The Privacy 

Act requires each Agency to publish in 

the Federal Register a SORN identifying 

and describing each system of records 

the Agency maintains, including the 

purposes for which the Agency uses 

information about individuals in the 

system, the routine uses for which the 

Agency discloses such information 

outside the Agency, and how individual 

record subjects can exercise their rights 

under the Privacy Act (for example, to 

determine if the system contains 

information about them). 

mstockstill on DSK4VPTVN1PROD with NOTICES

72688 Federal Register / Vol. 79, No. 235 / Monday, December 8, 2014 / Notices 

A. System Number 

09–10–0022 

B. SYSTEM NAME

FDA Commissioning of State and 

Local Officials, HHS/FDA/ORA. 

C. SECURITY CLASSIFICATION

Unclassified. 

D. SYSTEM LOCATION

Records are maintained at several 

FDA Headquarters locations and in 

component offices of the FDA, in both 

Montgomery County, MD and field 

locations across the United States. 

E. CATEGORIES OF INDIVIDUALS COVERED BY THE

SYSTEM

The records in this system will 

contain data collected from the FDA 

commissioning applications of 

individuals who are State and local 

officials who wish to be commissioned 

under section 702(a)(1)(A) of the FD&C 

Act. This information is gathered for the 

purpose of processing and validating 

each individual’s qualifications for 

commissioning, to initiate the 

mandatory background investigation, 

and to track the status of commissioned 

officials. 

Privacy Act notification, access, and 

amendment rights relative to the records 

maintained in this system are available 

only to individuals who are the subject 

of records in this system. The 

individuals who are the subjects of the 

records stored in this system are the 

State or local officials who are currently 

commissioned, have applied for a 

commission, and/or were commissioned 

or rejected in the past. Although records 

in the system may contain personally 

identifiable information related to other 

individuals, only the specified 

commissioned or commission-seeking 

individuals are considered subjects of 

records in this system. 

F. CATEGORIES OF RECORDS IN THE SYSTEM

The records in this system will 

include: Full name, aliases, date of 

birth, home address, work address, 

telephone number, work or personal 

email address, photograph, educational 

history, job title, agency, division, area 

of expertise, employment history, 

supervisor’s name, signature, and the 

outcome of the background 

investigation of individuals who apply 

for a commission. Should a 

commissioned individual with pocket 

credentials lose their credentials, he or 

she will typically file a police report 

and provide a copy of the report to FDA 

where it is kept in the individual’s 

commissioning file. In addition, the 

records in the system will describe the 

nature of the authority granted to a 

commissioned individual, the relevant 

regulatory program area, the date the 

commission was issued, and date of 

expiration. 

G. AUTHORITY FOR MAINTENANCE OF THE SYSTEM

The authorities for maintaining this 

system are: Section 702(a) of the FD&C 

Act, 44 U.S.C. 3101, and 5 U.S.C. 301. 

H. PURPOSE(S) OF THE SYSTEM

Relevant Agency personnel will use 

records from this system on a need-toknow basis to: 

• Centrally gather data enabling FDA 

to determine the suitability, eligibility, 

and qualifications of State and local 

officials to whom FDA might offer 

commissions; 

• enable FDA to securely commission 

and credential State and local officials 

who are particularly qualified to assist 

FDA in a special manner for which FDA 

credentials are required; 

• ensure the safety and security of 

FDA facilities, systems, information, 

and of facility occupants and users; 

• provide appropriate access to FDA 

information systems, networks, and 

resources; 

• enhance FDA’s ability to ensure the 

safety of FDA-regulated products 

through a secure commissioning 

process; and 

• centrally gather data on 

commissioned officials, thereby 

enabling FDA to efficiently maintain the 

commissioning program and to support 

activities, such as quickly ascertaining 

which officials are particularly qualified 

to carry out official responsibilities and 

providing this information as necessary 

to our State and local counterparts. 

I. ROUTINE USES OF RECORDS MAINTAINED IN

THE SYSTEM, INCLUDING CATEGORIES OF USERS

AND THE PURPOSES OF SUCH USES

These routine uses specify 

circumstances, in addition to those 

provided by the Privacy Act at 5 U.S.C. 

552a(b), under which records may be 

disclosed to recipients outside HHS, 

without the individual record subject’s 

prior written consent: 

• Public disclosures may be made (for 

example, on FDA’s Web site) of the 

names of commissioned officials, and 

other basic information, including the 

identification of their State or local 

agency, their job titles, the type of 

commission, any specific commissioned 

areas, and the date of their commission, 

to the extent disclosure is not an 

unwarranted invasion of personal 

privacy. 

• Disclosure may be made to 

appropriate Federal Agencies and 

Department contractors that have a need 

to know the information for the purpose 

of assisting the Department’s efforts to 

respond to a suspected or confirmed 

breach of the security or confidentiality 

of information maintained in this 

system of records, provided the 

information disclosed is relevant and 

necessary for that assistance. 

• Disclosure may be made to a 

Federal, State, local, territorial, tribal, 

foreign, or other public authority, on 

request, in connection with the hiring or 

retention of an employee, the issuance 

or retention of a security clearance, the 

letting of a contract, or the issuance or 

retention of a license, grant, or other 

benefit, to the extent that the 

information is relevant and necessary to 

the requesting Agency’s decision. No 

disclosure will be made unless the 

information has been determined to be 

sufficiently reliable to support a referral 

to another office within the Agency or 

to another Federal Agency for criminal, 

civil, administrative, personnel, or 

regulatory action. 

• Disclosure of system information 

may be made to a State, local, territorial, 

and tribal agencies or governments to 

provide copies of records that were 

originally provided to the Agency by 

that entity. 

• Disclosure may be made to Federal 

Agencies, contractors, and other 

individuals or entities who perform 

services for the Agency related to this 

system of records and who need access 

to the records to perform those services. 

Recipients shall be required to comply 

with the requirements of the Privacy Act 

of 1974, as amended, 5 U.S.C. 552a. 

• When a record on its face, or in 

conjunction with other records, 

indicates a violation or potential 

violation of law, whether civil, criminal, 

or regulatory in nature, disclosure may 

be made to the appropriate public 

authority, whether Federal, foreign, 

State, local, or tribal, or otherwise, 

responsible for enforcing, investigating, 

or prosecuting such violation, if the 

information disclosed is relevant to the 

responsibilities of the Agency or public 

authority. 

• Disclosure may be made to a court 

or other tribunal or adjudicative body in 

a proceeding, when: 

Æ The Agency or any component 

thereof; or 

Æ any employee of the Agency in his 

or her official capacity; or 

Æ any employee of the Agency in his 

or her individual capacity where the 

Department of Justice (DOJ) has agreed 

to represent the employee; or 

Æ the U.S. Government, is a party to 

the proceeding or has an interest in such 

proceeding and, by careful review, the 

Agency determines that the records are 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 235 / Monday, December 8, 2014 / Notices 72689 

both relevant and necessary to the 

proceeding and the use of such records 

is therefore deemed by the Agency to be 

for a purpose that is compatible with the 

purpose for which the Agency collected 

the records. 

• Disclosure may be made to the 

National Archives and Records 

Administration (NARA) and/or the 

General Services Administration for the 

purpose of records management 

inspections conducted under authority 

of 44 U.S.C. 2904 and 2906. 

• Disclosure may be made to the DOJ 

when: 

Æ The Agency or any component 

thereof; or 

Æ any employee of the Agency in his 

or her official capacity; or 

Æ any employee of the Agency in his 

or her individual capacity where the 

Agency or the DOJ has agreed to 

represent the employee; or 

Æ the U.S. Government, is a party to 

litigation or has an interest in such 

litigation and, by careful review, the 

Agency determines that the records are 

both relevant and necessary to the 

litigation and the use of such records by 

the DOJ is therefore deemed by the 

Agency to be for a purpose that is 

compatible with the purpose for which 

the Agency collected the records. 

• In the event HHS/FDA deems it 

desirable or necessary, in determining 

whether particular records are required 

to be disclosed under the Freedom of 

Information Act, disclosure may be 

made to the DOJ for the purpose of 

obtaining its advice. 

J. POLICIES AND PRACTICES FOR STORING, 

RETRIEVING, ACCESSING, RETAINING, AND

DISPOSING OF RECORDS IN THE SYSTEM

1. STORAGE

Records are maintained in hard copy 

files, image files, electronic hard drive, 

file servers, and other electronic data 

storage devices. 

2. RETRIEVABILITY

To retrieve information, the system 

database is typically queried using any 

of the internal data fields. The data 

fields encompass any data criterion that 

is entered into the system including, but 

not limited to, name, FDA region, 

credential number (if issued pocket 

credentials), certificate expiration date, 

State, program area, or authority. 

3. SAFEGUARDS

a. Authorized users. Access is 

restricted to FDA employees and 

contractors with a Level 5 or higher 

clearance who have a need for the 

records in the performance of their 

duties. 

b. Procedural and technical 

safeguards. Technical controls include 

identification and authentication of the 

authorized user, access control, audit 

and accountability, system and 

communication protection, timely 

account disablement/deletion, 

configuration management, 

maintenance, system and information 

integrity, media protection, and incident 

response. These controls extend to 

remote users as well. 

c. Physical safeguards. Physical 

safeguards include controlled-access 

buildings where all records (such as 

diskettes, computer listings, and paper 

documents) are maintained in secured 

areas, locked buildings, locked rooms, 

and locked cabinets. 

K. RETENTION AND DISPOSAL

Commissioning records are 

maintained in accordance with FDA’s 

Records Control Schedule and the 

applicable General Records Schedule 

and disposition schedules approved by 

NARA. Commissioning records fall 

under NARA approved citation N1– 

088–09–02 for Commissioning 

Documents, the Nationwide List of FDA 

Commissions, and Summary Reports of 

FDA Commissions. Commissioning 

documents are deleted/destroyed 5 

years after the end of the fiscal year in 

which a commission is revoked or 

expires. Records within the nationwide 

list of FDA commissions are deleted/

destroyed 5 years after the fiscal year 

when they become obsolete or are 

superseded. Summary reports of FDA 

commissions are deleted/destroyed after 

the nationwide list of FDA Commissions 

has been updated. 

L. SYSTEM MANAGER(S) AND ADDRESS

Ryan Cates, Food and Drug 

Administration, Office of Partnerships, 

Element Building, 12420 Parklawn Dr., 

Rockville, MD 20857, 301–796–5390, 

FAX: 301–827–3588, OP-ORA@

fda.hhs.gov. 

M. NOTIFICATION PROCEDURE

In accordance with 21 CFR part 21 

Subpart D, an individual may submit a 

request to the FDA Privacy Act 

Coordinator, with a notarized signature, 

to confirm whether records exist about 

him or her. Requests should be directed 

to the FDA Privacy Act Coordinator, 

Division of Freedom of Information, 

12420 Parklawn Dr., ELEM–1029, 

Rockville, MD 20857. An individual 

requesting notification via mail should 

certify in his or her request that he or 

she is the individual who he or she 

claims to be and that he or she 

understands that the knowing and 

willful request for or acquisition of a 

record pertaining to an individual under 

false pretenses is a criminal offense 

under the Privacy Act subject to a 

$5,000 fine, and indicate on the 

envelope and in a prominent manner in 

the request letter that he or she is 

making a ‘‘Privacy Act Request.’’ 

Additional details regarding notification 

request procedures appear in 21 CFR 

part 21, subpart D. A commission holder 

may also request an opportunity to 

review his or her own file by contacting 

the appropriate Regional Food and Drug 

Director. 

N. RECORD ACCESS PROCEDURES

Procedures are the same as above, in 

the Notification Procedure section. 

Requesters should also reasonably 

specify the record contents being 

sought. Some records may be exempt 

from access under 5 U.S.C. 552a(d)(5), if 

they are ‘‘compiled in reasonable 

anticipation of a civil action or 

proceeding.’’ If access to requested 

records is denied, the requester may 

appeal the denial to the FDA 

Commissioner. Additional details 

regarding record access procedures and 

identity verification requirements 

appear in 21 CFR part 21, subpart D. 

O. CONTESTING RECORD PROCEDURES

In addition to the procedures 

described above, requesters should 

reasonably identify the record, specify 

the information they are contesting, 

state the corrective action sought and 

the reasons for the correction, and 

provide information justifying why the 

record is not accurate, complete, timely, 

or relevant to an FDA purpose. Rules 

and procedures regarding amendment of 

Privacy Act records appear in 21 CFR 

part 21, subpart E. 

P. RECORD SOURCE CATEGORIES

Information in this system is obtained 

from the following sources: Directly 

from a commissioned individual or 

individual under consideration for 

commissioning; FDA employee; FDA 

contractor; sponsoring State, local or 

Federal agency; former sponsoring, 

employing or commissioning agency; 

other State, local or Federal agencies; 

contract employer; and the subject 

individual’s former employer. 

Q. RECORDS EXEMPTED FROM CERTAIN

PROVISIONS OF THE PRIVACY ACT

None. 

III. Comments 

Interested persons may submit either 

electronic comments regarding this 

document to http://www.regulations.gov 

or written comments to the Division of 

Dockets Management (see ADDRESSES). It 

is only necessary to send one set of 

comments. Identify comments with the 

docket number found in brackets in the 

mstockstill on DSK4VPTVN1PROD with NOTICES

72690 Federal Register / Vol. 79, No. 235 / Monday, December 8, 2014 / Notices 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday, and 

will be posted to the docket at http://

www.regulations.gov. 

Dated: December 1, 2014. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2014–28634 Filed 12–5–14; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–2031] 

Request for Nominations on the Food 

Advisory Committee 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is requesting that 

any industry organizations interested in 

participating in the selection of a 

nonvoting industry representative to 

serve on the Food Advisory Committee 

for the Center for Food Safety and 

Applied Nutrition (CFSAN) notify FDA 

in writing. FDA is also requesting 

nominations for a nonvoting industry 

representative(s) to serve on the Food 

Advisory Committee. A nominee may 

either be self-nominated or nominated 

by an organization to serve as a 

nonvoting industry representative. 

Nominations will be accepted for 

current vacancies effective with this 

notice. 

DATES: Any industry organization 

interested in participating in the 

selection of an appropriate nonvoting 

member to represent industry interests 

must send a letter stating that interest to 

the FDA by January 7, 2015 (see 

sections I and II of this document for 

further details). Concurrently, 

nomination materials for prospective 

candidates should be sent to FDA by 

January 7, 2015. 

ADDRESSES: All statements of interest 

from industry organizations interested 

in participating in the selection process 

of nonvoting industry representative 

nomination should be sent to Karen 

Strambler (see FOR FURTHER INFORMATION

CONTACT). All nominations for 

nonvoting industry representatives may 

be submitted electronically by accessing 

the FDA Advisory Committee 

Membership Nomination Portal: https:// 

www.accessdata.fda.gov/scripts/

FACTRSPortal/FACTRS/index.cfm or by 

mail to Advisory Committee Oversight 

and Management Staff, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 32, Rm. 5103, Silver Spring, 

MD 20993–0002. Information about 

becoming a member of an FDA advisory 

committee can also be obtained by 

visiting FDA’s Web site at http://

www.fda.gov/AdvisoryCommittees/

default.htm. 

FOR FURTHER INFORMATION CONTACT: 

Karen Strambler, Office of Policy, 

Regulations, and Social Science, Center 

for Food Safety and Applied Nutrition, 

5100 Paint Branch Pkwy., Rm. 1C–016, 

College Park, MD 20740, 2400–402– 

2589, karen.strambler@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency intends to add a nonvoting 

industry representative(s) to the 

following advisory committee: 

I. CFSAN Advisory Committee, Food 

Advisory Committee 

The Committee reviews and evaluates 

emerging food safety, nutrition and 

other food- or cosmetic-related health 

issues that FDA considers of primary 

importance for its food and cosmetics 

programs. The Committee may be 

charged with reviewing and evaluating 

available data and making 

recommendations on matters such as 

those relating to: (1) Broad scientific and 

technical food- or cosmetic-related 

issues; (2) the safety of food ingredients 

and new foods; (3) labeling of foods and 

cosmetics; (4) nutrient needs and 

nutritional adequacy; and (5) safe 

exposure limits for food contaminants. 

The Committee may also be asked to 

provide advice and make 

recommendations on ways of 

communicating to the public the 

potential risks associated with these 

issues and on approaches that might be 

considered for addressing the issues. 

II. Selection Procedure 

Any industry organization interested 

in participating in the selection of an 

appropriate nonvoting member to 

represent industry interests should send 

a letter stating that interest to the FDA 

contact (see FOR FURTHER INFORMATION

CONTACT) within 30 days of publication 

of this document (see DATES). Within the 

subsequent 30 days, FDA will send a 

letter to each organization that has 

expressed an interest, attaching a 

complete list of all such organizations; 

and a list of all nominees along with 

their current re ́sume ́s. The letter will 

also state that it is the responsibility of 

the interested organizations to confer 

with one another and to select a 

candidate, within 60 days after the 

receipt of the FDA letter, to serve as the 

nonvoting member to represent industry 

interests for the committee. The 

interested organizations are not bound 

by the list of nominees in selecting a 

candidate. However, if no individual is 

selected within 60 days, the 

Commissioner will select the nonvoting 

member to represent industry interests. 

III. Application Procedure 

Individuals may self-nominate and/or 

an organization may nominate one or 

more individuals to serve as a nonvoting 

industry representative. Contact 

information, a current curriculum vitae, 

and the name of the committee of 

interest should be sent to the FDA 

Advisory Committee Membership 

Nomination Portal (see ADDRESSES) 

within 30 days of publication of this 

document (see DATES). FDA will forward 

all nominations to the organizations 

expressing interest in participating in 

the selection process for the committee. 

(Persons who nominate themselves as 

nonvoting industry representatives will 

not participate in the selection process). 

FDA seeks to include the views of 

women, and men, members of all racial 

and ethnic groups and individuals with 

and without disabilities on its advisory 

committees and, therefore encourages 

nominations of appropriately qualified 

candidates from these groups. 

This notice is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app. 2) and 21 CFR part 14, 

relating to advisory committees. 

Dated: December 1, 2014. 

Jill Hartzler Warner, 

Associate Commissioner for Special Medical 

Programs. 

[FR Doc. 2014–28652 Filed 12–5–14; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: Public 

Comment Request 

AGENCY: Health Resources and Services 

Administration, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement for opportunity for public 

comment on proposed data collection 

projects (Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995), the 

Health Resources and Services 

Administration (HRSA) announces 

plans to submit an Information 

Collection Request (ICR), described 

mstockstill on DSK4VPTVN1PROD with NOTICES